Gujarat Kidney & Super Speciality Ltd Q3 FY2025-2026 Results: Summary

Revenue
₹23.31Cr
Net Profits
₹2.94Cr
Net Profit Margins
12.61%
Highlights
Revenue:

Gujarat Kidney & Super Speciality Ltd’s revenue jumped 96.88% since last year same period to ₹23.31Cr in the Q3 2025-2026. On a quarterly growth basis, Gujarat Kidney & Super Speciality Ltd has generated 79.03% jump in its revenue since last 3-months.

Net Profits:

Gujarat Kidney & Super Speciality Ltd’s net profit jumped 17.6% since last year same period to ₹2.94Cr in the Q3 2025-2026. On a quarterly growth basis, Gujarat Kidney & Super Speciality Ltd has generated 10.11% jump in its net profits since last 3-months.

Net Profit Margins:

Gujarat Kidney & Super Speciality Ltd’s net profit margin fell -40.27% since last year same period to 12.61% in the Q3 2025-2026. On a quarterly growth basis, Gujarat Kidney & Super Speciality Ltd has generated -38.5% fall in its net profit margins since last 3-months.

FAQs

What was the revenue for Gujarat Kidney & Super Speciality Ltd in Q3 results 2025?

The revenue for Gujarat Kidney & Super Speciality Ltd in the Q3 results 2025 was ₹23.31Cr.

What was the net profit for Gujarat Kidney & Super Speciality Ltd in Q3 results 2025?

The net profit for Gujarat Kidney & Super Speciality Ltd in the Q3 results 2025 was ₹2.94Cr.

What was the net profit margin for Gujarat Kidney & Super Speciality Ltd in Q3 results 2025?

The net profit margin for Gujarat Kidney & Super Speciality Ltd in the Q3 results 2025 was 12.61%.

What was the revenue for Gujarat Kidney & Super Speciality Ltd in Q3 results 2024?

The revenue for Gujarat Kidney & Super Speciality Ltd in the Q3 results 2024 was ₹11.84Cr.

What was the net profit for Gujarat Kidney & Super Speciality Ltd in Q3 results 2024?

The net profit for Gujarat Kidney & Super Speciality Ltd in the Q3 results 2024 was ₹2.50Cr.

What was the net profit margin for Gujarat Kidney & Super Speciality Ltd in Q3 results 2024?

The net profit margin for Gujarat Kidney & Super Speciality Ltd in the Q3 results 2024 was 21.11%.